Jane Street Group, LLC Vallon Pharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
About Vallon Pharmaceuticals, Inc.
- Ticker VLON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,512,800
- Description
- Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...